Liver transplant-facilitated recovery of MAIT cell from dysregulation in HBV-related liver failure demonstrates clinical benefits
Xiufang Weng(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhishui Chen(Tongji Hospital), Peng Zhu(Dalian Medical University), Mi Wu(Huazhong Agricultural University), Xue Cheng(Wuhan University), Xiaosheng Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiongwen Wu, Ting Zhou(The Affiliated Yongchuan Hospital of Chongqing Medical University), Wei Wang(Capital Medical University), Haoquan Zhang(Tongji Hospital), Ying Jiang(Huazhong University of Science and Technology), Qing Wei(Tongji Hospital), Chen Dai(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhihui Liang(Tongji University)
Cited by 0
Related Papers
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|2022|267
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib
|Journal for ImmunoTherapy of Cancer|2020|153
Targeting Piezo1 unleashes innate immunity against cancer and infectious disease
|Science Immunology|2020|151
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
|Pharmacological Reviews|2024|127